{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:53:25Z","timestamp":1792450405169,"version":"4.5.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1097\/gme.0b013e318259eaf3","type":"journal-article","created":{"date-parts":[[2012,10,26]],"date-time":"2012-10-26T07:13:35Z","timestamp":1351235615000},"page":"64-71","source":"Crossref","is-referenced-by-count":4,"title":["Baseline hysteroscopic assessment of endometrium in asymptomatic postmenopausal women with estrogen receptor\u2013positive breast cancer"],"prefix":"10.1097","volume":"20","author":[{"given":"Daniel Mar\u00eda Lubi\u00e1n","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurena Gonz\u00e1lez","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel Vilar","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Iglesias","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel L\u00f3pez","family":"Reynaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Comino","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20210211","first-page":"332","article-title":"Second cancers after adjuvant therapy for breast cancer.","volume":"88","author":"Curtis","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"R4-11-20210211","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7326\/0003-4819-137-1-200207020-00017","article-title":"Chemoprevention of breast cancer: a review of the evidence for the U.S. Preventive Services Task Force.","volume":"137","author":"Kinsinger","year":"2002","journal-title":"Ann Intern Med"},{"key":"R5-11-20210211","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1005999008736","article-title":"Variation in endometrial thickening in women with amenorrhea on tamoxifen.","volume":"48","author":"Chang","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"R6-11-20210211","first-page":"660","article-title":"Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.","volume":"81","author":"Lahti","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R7-11-20210211","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/bjc.1994.116","article-title":"Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroids overgrowth.","volume":"69","author":"Cohen","year":"1994","journal-title":"Br J Cancer"},{"key":"R8-11-20210211","first-page":"CD000486","article-title":"Tamoxifen for early breast cancer (Cochrane review).","volume":"1","year":"2001","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-11-20210211","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1097\/00006250-200606000-00057","article-title":"ACOG committee opinion. No. 336: tamoxifen and uterine cancer.","volume":"107","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R10-11-20210211","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0301-2115(01)00516-4","article-title":"Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring.","volume":"101","author":"Vosse","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R11-11-20210211","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0959-8049(00)00217-3","article-title":"Identification of women at high risk of developing endometrial cancer on tamoxifen.","volume":"36","author":"Berliere","year":"2000","journal-title":"Eur J Cancer"},{"key":"R12-11-20210211","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0090-8258(03)00276-2","article-title":"Recurrent endometrial polyps in postmenopausal breast cancer patients on tamoxifen.","volume":"90","author":"Biron-Shental","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R13-11-20210211","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/gme.0b013e3181ca2513","article-title":"Value of the progesterone test in screening for endometrial pathology in asymptomatic postmenopausal women receiving treatment with tamoxifen.","volume":"17","author":"Lubian Lopez","year":"2010","journal-title":"Menopause"},{"key":"R14-11-20210211","first-page":"667","article-title":"Histopathologic findings in thickened endometria, as measured by ultrasound in asymptomatic, postmenopausal breast cancer patients on various adjuvant treatment including tamoxifen.","volume":"18","author":"Willen","year":"1998","journal-title":"Anticancer Res"},{"key":"R15-11-20210211","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0029-7844(97)00591-7","article-title":"Uterine side effects of tamoxifen: a need for systematic pretreatment screening.","volume":"91","author":"Berliere","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R16-11-20210211","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1200\/JCO.2000.18.20.3464","article-title":"Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.","volume":"18","author":"Gerber","year":"2000","journal-title":"J Clin Oncol"},{"key":"R17-11-20210211","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(05)78091-0","article-title":"Longitudinal hysteroscopic follow-up during tamoxifen treatment.","volume":"351","author":"Neven","year":"1998","journal-title":"Lancet"},{"key":"R19-11-20210211","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1471-0528.2003.02120.x","article-title":"The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.","volume":"110","author":"Duffy","year":"2003","journal-title":"BJOG"},{"key":"R20-11-20210211","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2005.03.036","article-title":"Baseline endometrial assessment before tamoxifen for breast cancer in asymptomatic menopausal women.","volume":"98","author":"Garuti","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R21-11-20210211","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejogrb.2006.04.001","article-title":"Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.","volume":"132","author":"Garuti","year":"2007","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R22-11-20210211","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1093\/humrep\/17.9.2435","article-title":"Advanced operative office hysteroscopy without anaesthesia: analysis of 501 cases treated with a 5 Fr bipolar electrode.","volume":"17","author":"Bettocchi","year":"2002","journal-title":"Hum Reprod"},{"key":"R23-11-20210211","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ygyno.2006.04.004","article-title":"Prospective endometrial assessment of breast cancer patients treated with third generation aromatase inhibitors.","volume":"103","author":"Garuti","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R24-11-20210211","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/annonc\/mdp358","article-title":"Long-term endometrial effects in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled trial of exemestane versus continued tamoxifen after 23 years tamoxifen.","volume":"21","author":"Bertelli","year":"2010","journal-title":"Ann Oncol"},{"key":"R26-11-20210211","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1074-3804(05)60579-8","article-title":"Accuracy of hysteroscopy in predicting histopathology of endometrium in 1500 women.","volume":"8","author":"Garuti","year":"2001","journal-title":"J Am Assoc Gynecol Laparosc"},{"key":"R28-11-20210211","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1067\/mob.2001.111088","article-title":"An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms.","volume":"184","author":"Fleischer","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R29-11-20210211","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0002-9378(91)90084-5","article-title":"Endometrial morphology in asymptomatic postmenopausal women.","volume":"165","author":"Archer","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"R30-11-20210211","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/uog.6259","article-title":"Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20-74 years.","volume":"33","author":"Dreisler","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R31-11-20210211","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0020-7292(01)00528-8","article-title":"Tamoxifen-induced endometrial changes in postmenopausal women with breast carcinoma.","volume":"76","author":"Juneja","year":"2002","journal-title":"Int J Gynecol Obstet"},{"key":"R32-11-20210211","first-page":"1099","article-title":"The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment.","volume":"110","author":"Duffy","year":"2005","journal-title":"Hum Reprod"},{"key":"R33-11-20210211","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/gyno.1999.5519","article-title":"Tamoxifen and endometrial pathology. A prospective study.","volume":"75","author":"Seoud","year":"1999","journal-title":"Gynecol Oncol"},{"key":"R34-11-20210211","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0301-2115(99)00291-2","article-title":"Uterine side effects of treatment with tamoxifen.","volume":"92","author":"Andia","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R35-11-20210211","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0029-7844(96)00108-1","article-title":"2500 outpatient diagnostic hysteroscopies.","volume":"88","author":"Nagele","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R36-11-20210211","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1006\/gyno.2002.6783","article-title":"Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake.","volume":"86","author":"Garuti","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R37-11-20210211","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1471-0528.2003.02472.x","article-title":"Saline contrast hysterosonography in abnormal uterine bleeding: a systematic review and meta-analysis.","volume":"110","author":"de Kroon","year":"2003","journal-title":"BJOG"},{"key":"R38-11-20210211","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00404-008-0560-4","article-title":"Diagnostic value of hysteroscopy and hysterosonography in endometrial abnormalities in asymptomatic postmenopausal women.","volume":"278","author":"Gumus","year":"2008","journal-title":"Arch Gynecol Obstet"},{"key":"R40-11-20210211","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1471-0528.1998.tb10185.x","article-title":"Flexible outpatient hysteroscopy without anaesthesia: a safe, successful and well tolerated procedure.","volume":"105","author":"Kremer","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R41-11-20210211","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4065\/mcp.2010.0794","article-title":"Challenges in the gynecologic care of premenopausal women with breast cancer.","volume":"86","author":"Bakkum-Gamez","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"R42-11-20210211","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.maturitas.2007.04.010","article-title":"Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.","volume":"57","author":"Antunes","year":"2007","journal-title":"Maturitas"},{"key":"R43-11-20210211","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/gme.0b013e31821e23a1","article-title":"Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics.","volume":"18","author":"Costa-Paiva","year":"2011","journal-title":"Menopause"},{"key":"R44-11-20210211","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-7819-3-8","article-title":"Age dependent association of endometrial polyps with increased risk of cancer involvement.","volume":"3","author":"Hileeto","year":"2005","journal-title":"World J Surg Oncol"},{"key":"R45-11-20210211","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1067\/mob.2003.247","article-title":"Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps.","volume":"188","author":"Savelli","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R46-11-20210211","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijgo.2006.07.007","article-title":"Hysteroscopic evaluation of endometrial polyps.","volume":"95","author":"Fernandez-Parra","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"R47-11-20210211","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2004.02.002","article-title":"The malignant potential of endometrial polyps.","volume":"115","author":"Ben-Arie","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R48-11-20210211","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres ALERT Group. Assessment of liver and endometrial cancer risk following tamoxifen.","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet"},{"key":"R49-11-20210211","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.maturitas.2007.08.005","article-title":"Endometrial polyps in pre- and postmenopausal women: factors associated with malignancy.","volume":"59","author":"Cohen","year":"2008","journal-title":"Maturitas"},{"key":"R50-11-20210211","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1023\/A:1005999008736","article-title":"Variation in endometrial thickening in women with amenorrhea on tamoxifen.","volume":"48","author":"Chang","year":"1998","journal-title":"Breast Cancer Res Treat"},{"key":"R51-11-20210211","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0002-9378(99)70210-3","article-title":"Endometrial cancer in polyps associated with tamoxifen use.","volume":"180","author":"Ramondetta","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R52-11-20210211","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomized controlled trial.","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet"},{"key":"R53-11-20210211","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1056\/NEJMoa0810818","article-title":"Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer.","volume":"361","author":"Mouridsen","year":"2009","journal-title":"N Engl J Med"},{"key":"R54-11-20210211","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(10)62312-4","article-title":"Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial.","volume":"377","author":"van de Velde","year":"2011","journal-title":"Lancet"},{"key":"R55-11-20210211","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0029-7844(97)00591-7","article-title":"Uterine side effects of tamoxifen: a need for systematic pretreatment screening.","volume":"91","author":"Berliere","year":"1998","journal-title":"Obstet Gynecol"},{"key":"R56-11-20210211","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2008.20.5179","article-title":"American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction.","volume":"27","author":"Visvanathan","year":"2009","journal-title":"J Clin Oncol"},{"key":"R57-11-20210211","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0020-7292(01)00476-3","article-title":"Endometrial histologic changes in post-menopausal breast cancer patients using tamoxifen.","volume":"75","author":"Marchesoni","year":"2001","journal-title":"Int J Gynaecol Obstet"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00042192-201301000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T01:35:28Z","timestamp":1618277728000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042192-201301000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e318259eaf3","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}